Poway, CA, March 15, 2022 — Cellipont Bioservices, a contract development and manufacturing organization (CDMO) with more than 15 years of experience in manufacturing cell therapies, today announced the addition of several experienced cell therapy executives to its leadership team.
Mike O’Mara has joined Cellipont as Chief Operating Officer, Denise Krohn has joined as Senior Vice President, Quality & Regulatory and Scott Broughton has joined as Senior Vice President, Sales & Marketing. Current COO Carolyn Wrightson will become Chief Technology Officer.
Cellipont President & CEO Deborah Wild commented, “With the addition of these accomplished leaders to our team, Cellipont is poised to accelerate the fulfillment of our mission to help our innovative cell therapy clients expand patient access to life changing medicines. The fact that these proven individuals chose to join Cellipont is a validation of the team, vision and strategy we have in place.”